Research and Markets: China Diabetes Care Devices Market Outlook to 2017 - Glucose Monitoring and Insulin Delivery

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/5bc510/china_diabetes_car) has announced the addition of GlobalData 's new report "China Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery" to their offering.

GlobalData's new report, China Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery provides key market data on the China Diabetes Care Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within two market categories:

• Glucose Monitoring
• Insulin Delivery

The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

• Market size and company share data for Diabetes Care Devices market categories.
• 2010 company shares and distribution shares data for each of the two market categories.
• Global corporate-level profiles of key companies operating within the China Diabetes Care Devices market.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the China Diabetes Care Devices competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

Companies Mentioned:

• ARKRAY, Inc.
• Abbott Laboratories
• Animas Corporation
• Bayer HealthCare AG
• Becton, Dickinson and Company
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• LifeScan, Inc.
• Medtronic, Inc.
• Novo Nordisk A/S
• Sanofi
• Terumo Corporation

For more information, including table of contents, please visit http://www.researchandmarkets.com/research/5bc510/china_diabetes_car